Logo image
Open Research University homepage
Surrey researchers Sign in
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial
Journal article   Open access   Peer reviewed

SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial

Merete B. Long, Hani Abo-Leyah, Yan Hui Giam, Thenmalar Vadiveloo, Rebecca C. Hull, Holly R. Keir, Thomas Pembridge, Daniela Alferes De Lima, Lilia Delgado, Sarah K. Inglis, …
ERJ open research, Vol.10(2), p.917
01/03/2024
PMID: 38469377

Abstract

Original s
Treatment with stabilised synthetic sulforaphane (SFX-01, 300 mg oral capsule) once daily for 14 days did not modulate key Nrf2 targets or improve clinical outcomes in patients hospitalised with CAP mainly due to SARS-CoV-2 infection https://bit.ly/4280Tvb
url
https://doi.org/10.1183/23120541.00917-2023View
Published (Version of record) Open

Metrics

Details

Logo image

Usage Policy